- 康弘藥業
- 30.760-0.410 (-1.315%)
盈利能力分析
- 11.593
- 14.477
- 14.209
- 13.804
- 7.110
- 10.753
- 13.331
- 12.858
- 12.219
- 6.034
- 11.553
- 14.402
- 14.057
- 13.516
- 6.877
邊際利潤分析
- 90.329
- 89.524
- 88.922
- 88.550
- 90.164
- 33.889
- 31.023
- 31.866
- 29.960
- 9.851
- 32.201
- 28.976
- 29.857
- 29.075
- 9.960
- 28.178
- 26.434
- 26.055
- 25.547
- 11.679
收益指標分析
- 98.086
- 95.563
- 93.231
- 88.628
- 111.772
- 0.856
- 3.417
- 3.582
- 3.694
- 6.717
- -1.625
- -2.129
- -2.200
- 1.449
- 9.721
償債能力分析
- 10.356
- 9.601
- 8.107
- 6.097
- 5.542
- 9.786
- 9.011
- 7.490
- 5.620
- 5.099
- 7.295
- 7.440
- 8.415
- 10.541
- 12.235
- -0.153
- -0.067
- -0.149
- -0.179
- -0.232
- -65,097.901
- -148,405.851
- -66,839.353
- -55,068.346
- -41,848.930
- 1,273.141
- 1,244.941
- 1,087.270
- 848.043
- 715.530
- -28.101
- -20.696
- -22.569
- -21.924
- -10.460
營運能力分析
- 12.823
- 13.659
- 14.101
- 17.676
- 25.642
- 297.789
- 305.027
- 301.598
- 290.659
- 271.703
回顧25 展望26
大國博弈
More